AtonRa Partners’s Procept Biorobotics PRCT Stock Holding History

AtonRa Partners’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$617K	Sell	14,715 -1,747	-11%	-$59.5K	1.23%	21
2023 Q3	$540K	Sell	16,462 -73	-0.4%	-$2.49K	1.13%	23
2023 Q2	$585K	Sell	16,535 -2,907	-15%	-$96.1K	0.91%	40
2023 Q1	$552K	Sell	19,442 -2,734	-12%	-$96.4K	0.81%	48
2022 Q4	$921K	Sell	22,176 -3,813	-15%	-$164K	1.17%	29
2022 Q3	$1.08M	Buy	25,989 +8,860	+52%	+$353K	1.06%	36
2022 Q2	$560K	Buy	+17,129	New	+$623K	0.51%	95

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AtonRa Partners's PRCT Position: Q4 2023 in Review

AtonRa Partners reduced its Procept Biorobotics (PRCT) stake by 11% in Q4 2023, selling an estimated $59.5K and leaving 14,715 shares worth $617K. The position accounts for 1.23% of the portfolio, ranked #21.

AtonRa Partners first reported a position in PRCT in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.08M in Q3 2022. 145 funds tracked by Wall St. Rank hold PRCT as of Q4 2023.

AtonRa Partners held 14,715 shares of Procept Biorobotics worth $617K as of Q4 2023.
AtonRa Partners sold 1,747 Procept Biorobotics shares in Q4 2023, an estimated $59.5K.
Procept Biorobotics made up 1.23% of AtonRa Partners's portfolio in Q4 2023, its #21 holding.
AtonRa Partners first reported a position in Procept Biorobotics in Q2 2022 and has held it in 7 quarters since.
AtonRa Partners's Procept Biorobotics position peaked at $1.08M in Q3 2022.
145 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.